Speciality Medi.

Which are the latest news on Speciality Medi.?

Why is Speciality Medicines Ltd falling/rising?

As of 05-Sep, the stock price of Speciality Medicines Ltd is rising to 150.00, reflecting a 3.45% increase. This rise is driven by strong sector performance and a notable intraday gain, although longer-term trends indicate potential caution due to declining investor participation and trading below key moving averages.

As of 05-Sep, the stock price of Speciality Medicines Ltd is rising, currently at 150.00, which reflects a change of 5.0 or 3.45% increase. This upward movement can be attributed to several factors observed today. Notably, the stock has outperformed its sector by 3.9%, indicating a stronger performance relative to its peers. Additionally, it has experienced a trend reversal, gaining after two consecutive days of decline, which may signal a shift in investor sentiment.<BR><BR>The stock opened with a significant gap up of 6.03%, reaching an intraday high of Rs 154, which is a 6.21% increase from the previous close. However, it is important to note that despite this rise, Speciality Medicines Ltd is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting that while there is a short-term gain, the longer-term trend may still be downward.<BR><BR>Furthermore, there has been a decline in investor participation, with delivery volume dropping by 42.86% against the 5-day average, which could indicate a lack of sustained interest from investors. Despite this, the stock remains liquid enough for trading, based on its average traded value.<BR><BR>In summary, the rise in the stock price of Speciality Medicines Ltd today is primarily driven by a strong performance relative to its sector and a notable intraday gain, despite underlying trends that may suggest caution moving forward.

What does Speciality Medi. do?

Speciality Medicines Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, with a market cap of INR 136 Cr. It currently has no reported sales or profits, a P/E ratio of 10.00, and a Return on Equity of 18.30%.

Overview: Speciality Medicines Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Micro Cap company.<BR><BR>History: No specific details regarding the incorporation year or status changes are available. Additionally, there are no reported sales or profit figures for the latest quarter.<BR><BR>Financial Snapshot: Most recent Net Sales: N/A; Most recent Net Profit: N/A; Market-cap value: INR 136 Cr; Market-cap category: Micro Cap.<BR><BR>Key Metrics: P/E: 10.00; Industry P/E: 37; Dividend Yield: 0.00%; Debt-Equity: -0.25; Return on Equity (ROE): 18.30%; Price-to-Book: 1.91.<BR><BR>Contact Details: Registrar Address: Not available; Phone: N/A; Email: N/A; Website: N/A.

Who are the peers of the Speciality Medi.?

Speciality Medi.'s peers include Smruthi Organic, Parnax Lab, and Quest Laborato., among others. Parnax Lab and Quest Laborato. show excellent management and growth, while Smruthi Organic has the highest 1-year return at 25.74%, and Panch.Organics has the lowest at -23.17%.

Peers: The peers of Speciality Medi. are Smruthi Organic, Parnax Lab, Panch.Organics, Auro Labs., Lactose (India), Bal Pharma, Alpa Laboratorie, Kimia Bioscien., Quest Laborato., Balaxi Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Parnax Lab and Quest Laborato., while Average management risk is found at Smruthi Organic, Auro Labs., Bal Pharma, Alpa Laboratorie, and Balaxi Pharma, and the rest have Below Average management risk. Growth is Good at Parnax Lab and Quest Laborato., while Below Average growth is noted at Smruthi Organic, Panch.Organics, Auro Labs., Lactose (India), Bal Pharma, Alpa Laboratorie, Kimia Bioscien., and Balaxi Pharma, and the rest have Average growth. Capital Structure is Excellent at Parnax Lab and Quest Laborato., while Good capital structure is found at Smruthi Organic and Alpa Laboratorie, and the rest have Below Average or Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Smruthi Organic at 25.74%, while the peer with the lowest is Panch.Organics at -23.17%. Speciality Medi.'s 1-year return is not available for comparison. Additionally, Lactose (India), Alpa Laboratorie, Kimia Bioscien., and Bal Pharma have negative six-month returns.

How big is Speciality Medi.?

As of 14th August, Speciality Medicines Ltd has a market capitalization of 139.00 Cr, classified as a Micro Cap, with no available data for Net Sales or Net Profit in the latest four quarters. The balance sheet as of March 2025 shows Shareholder's Funds of 30.42 Cr and Total Assets of 39.98 Cr.

As of 14th August, <BR><BR>Market Cap: Speciality Medicines Ltd has a market capitalization of 139.00 Cr, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 30.42 Cr and Total Assets totaling 39.98 Cr.

When is the next results date for Speciality Medicines Ltd?

The next results date for Speciality Medicines Ltd is 28 May 2026.

The next results date for Speciality Medicines Ltd is scheduled for 28 May 2026.